- Home
- TRU vs WGSWW Comparison
TRU vs WGSWW Comparison
Compare TRU & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRU
- WGSWW
- Stock Information
- Founded
- TRU 1968
- WGSWW 2017
- Country
- TRU United States
- WGSWW United States
- Employees
- TRU N/A
- WGSWW 1000
- Industry
- TRU Finance: Consumer Services
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- TRU Finance
- WGSWW Technology
- Exchange
- TRU Nasdaq
- WGSWW Nasdaq
- Market Cap
- TRU N/A
- WGSWW N/A
- IPO Year
- TRU 2015
- WGSWW N/A
- Fundamental
- Price
- TRU $85.41
- WGSWW $0.07
- Analyst Decision
- TRU Buy
- WGSWW
- Analyst Count
- TRU 12
- WGSWW 0
- Target Price
- TRU $112.09
- WGSWW N/A
- AVG Volume (30 Days)
- TRU 2.0M
- WGSWW 36.6K
- Earning Date
- TRU 07-24-2025
- WGSWW 02-18-2025
- Dividend Yield
- TRU 0.54%
- WGSWW N/A
- EPS Growth
- TRU N/A
- WGSWW N/A
- EPS
- TRU 1.87
- WGSWW N/A
- Revenue
- TRU $4,258,300,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- TRU $6.46
- WGSWW N/A
- Revenue Next Year
- TRU $9.05
- WGSWW N/A
- P/E Ratio
- TRU $45.79
- WGSWW N/A
- Revenue Growth
- TRU 8.85
- WGSWW 50.79
- 52 Week Low
- TRU $66.38
- WGSWW $0.17
- 52 Week High
- TRU $113.17
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- TRU 48.88
- WGSWW N/A
- Support Level
- TRU $81.82
- WGSWW N/A
- Resistance Level
- TRU $86.89
- WGSWW N/A
- Average True Range (ATR)
- TRU 2.67
- WGSWW 0.00
- MACD
- TRU -0.71
- WGSWW 0.00
- Stochastic Oscillator
- TRU 24.95
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.